XML 181 R155.htm IDEA: XBRL DOCUMENT v3.24.3
FAIR VALUE MEASUREMENT - Valuation Techniques and Inputs for Level 3 Nonrecurring Fair Value Measurements (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
decimal
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
decimal
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
decimal
Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings $ (25,000,000) $ (94,000,000) $ (42,000,000) $ (173,000,000)  
Nonrecurring | Level 3          
Valuation techniques and inputs          
Loans HFS 244,000,000   244,000,000   $ 676,000,000
Loans         296,000,000
Other real estate owned 7,000,000   7,000,000   3,000,000
Price-based | Level 3          
Valuation techniques and inputs          
Non-marketable equities 222,000,000   222,000,000    
Price-based | Nonrecurring | Level 3          
Valuation techniques and inputs          
Non-marketable equities 70,000,000   70,000,000   250,000,000
Price-based | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans HFS $ 211,000,000   $ 211,000,000   $ 674,000,000
Price-based | Price | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities         0.40
Non-marketable equities 0.55   0.55    
Price-based | Price | Level 3 | Maximum          
Valuation techniques and inputs          
Non-marketable equities         158.92
Non-marketable equities 3,190.93   3,190.93    
Price-based | Price | Level 3 | Weighted Average          
Valuation techniques and inputs          
Non-marketable equities         56.78
Non-marketable equities 1,756.38   1,756.38    
Price-based | Price | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans HFS 95.73   95.73   67.50
Non-marketable equities         1.57
Non-marketable equities 1.23   1.23    
Nonrecurring fair value changes included in earnings          
Other real estate owned 0   0    
Price-based | Price | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Loans HFS 100.00   100.00   100.00
Non-marketable equities         2,637
Non-marketable equities 519.72   519.72    
Nonrecurring fair value changes included in earnings          
Other real estate owned 8,427   8,427    
Price-based | Price | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Loans HFS 97.91   97.91   93.39
Non-marketable equities         1,114.06
Non-marketable equities 110.65   110.65    
Nonrecurring fair value changes included in earnings          
Other real estate owned 123.38   123.38    
Price-based | Appraised value (in millions) | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Other real estate owned         401,042
Nonrecurring fair value changes included in earnings          
Other real estate owned 21,600   21,600    
Price-based | Appraised value (in millions) | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Other real estate owned         2,061,700
Nonrecurring fair value changes included in earnings          
Other real estate owned 342,000   342,000    
Price-based | Appraised value (in millions) | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Other real estate owned         155,696
Nonrecurring fair value changes included in earnings          
Other real estate owned 194,563   194,563    
Price-based | Revenue multiple | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities         $ 50,000,000
Price-based | Illiquidity discount | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities 0.1840   0.1840    
Price-based | Illiquidity discount | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Non-marketable equities 0.1950   0.1950    
Price-based | Illiquidity discount | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Non-marketable equities 0.1895   0.1895    
Recovery analysis | Nonrecurring | Level 3          
Valuation techniques and inputs          
Loans $ 149,000,000   $ 149,000,000    
Recovery analysis | Measurement Input, Discounted Cash Flow | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans 12,000   12,000    
Recovery analysis | Measurement Input, Discounted Cash Flow | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Loans 78,595,495   78,595,495    
Recovery analysis | Measurement Input, Discounted Cash Flow | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Loans 40,009,156   40,009,156    
Recovery analysis | Appraised value (in millions) | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans     12,000
Recovery analysis | Appraised value (in millions) | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Loans     75,997,078
Recovery analysis | Appraised value (in millions) | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Loans     46,121,923
Appraised value | Nonrecurring | Level 3          
Valuation techniques and inputs          
Loans $ 62,000,000   $ 62,000,000    
Comparable analysis | Nonrecurring | Level 3          
Valuation techniques and inputs          
Non-marketable equities $ 33,000,000   $ 33,000,000    
Comparable analysis | Revenue multiple | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities | decimal 6.10   6.10   2.30
Comparable analysis | Revenue multiple | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Non-marketable equities | decimal 9.19   9.19   35.70
Comparable analysis | Revenue multiple | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Non-marketable equities | decimal 6.89   6.89   11.69
Comparables analysis | Level 3          
Valuation techniques and inputs          
Non-marketable equities $ 228,000,000   $ 228,000,000   $ 366,000,000
Comparables analysis | Nonrecurring | Level 3          
Valuation techniques and inputs          
Non-marketable equities         $ 109,000,000
Comparables analysis | Revenue multiple | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities | decimal 4.30   4.30   2.80
Comparables analysis | Revenue multiple | Level 3 | Maximum          
Valuation techniques and inputs          
Non-marketable equities | decimal 16.26   16.26   13.40
Comparables analysis | Revenue multiple | Level 3 | Weighted Average          
Valuation techniques and inputs          
Non-marketable equities | decimal 11.95   11.95   12.28
Comparables analysis | Illiquidity discount | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities 0.0740   0.0740   0.0800
Comparables analysis | Illiquidity discount | Level 3 | Maximum          
Valuation techniques and inputs          
Non-marketable equities 0.3300   0.3300   0.1000
Comparables analysis | Illiquidity discount | Level 3 | Weighted Average          
Valuation techniques and inputs          
Non-marketable equities 0.1435   0.1435   0.0882
Loans held-for-sale | Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings $ (1,000,000) 0 $ (46,000,000) 6,000,000  
Other real estate owned | Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings 0 0 0 0  
Loans | Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings (16,000,000) (82,000,000) (16,000,000) (110,000,000)  
Non-marketable equity securities | Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings $ (8,000,000) $ (12,000,000) $ 20,000,000 $ (69,000,000)